FAMILIAL ALZHEIMERS-DISEASE WITH THE AMYLOID PRECURSOR PROTEIN POSITION-717 MUTATION AND SPORADIC ALZHEIMERS-DISEASE HAVE THE SAME CYTOSKELETAL PATHOLOGY

被引:85
作者
LANTOS, PL
LUTHERT, PJ
HANGER, D
ANDERTON, BH
MULLAN, M
ROSSOR, M
机构
[1] INST PSYCHIAT,DEPT NEUROSCI,LONDON SE5 8AF,ENGLAND
[2] ST MARYS HOSP,SCH MED,DEPT MOLEC GENET,LONDON,ENGLAND
[3] ST MARYS HOSP,SCH MED,DEPT NEUROL,LONDON,ENGLAND
基金
英国医学研究理事会;
关键词
AMYLOID PRECURSOR PROTEIN; FAMILIAL ALZHEIMERS DISEASE; CYTOSKELETON; LEWY BODY; NEUROFILAMENT; TAU;
D O I
10.1016/0304-3940(92)90408-Y
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The cytoskeletal pathology of a patient with familial Alzheimer's disease (AD) associated with the probably causal amyloid precursor protein (APP) codon 717 Val --> Ile mutation is described. In addition to moderately extensive beta-A4 protein deposition within the substance of the brain and in blood vessel walls (congophilic angiopathy), there was abundant cytoskeletal pathology in the form of neurofibrillary tangles, plaque neurites and neuropil threads. Interestingly, plentiful cortical and subcortical Lewy bodies were also seen. In order to compare the cytoskeletal pathology in this case with that seen in sporadic cases of AD we (1) studied the immunohistochemical profile of the amyloid and cytoskeletal pathology with antibodies to beta-A4 protein, tau, phosphorylated neurofilament epitopes and ubiquitin and (2) performed a biochemical fractionation and Western blot analysis for the abnormally phosphorylated form of tau (A68) characteristically seen in AD. No substantial difference between the familial case and sporadic cases could be found. We conclude that it is now reasonable to hypothesise that an abnormality in APP metabolism is responsible not only for the deposition of beta-A4 protein, but also for the range of cytoskeletal pathology, typical of AD.
引用
收藏
页码:221 / 224
页数:4
相关论文
共 20 条
  • [1] DEFINED NEUROFILAMENT, TAU-AMYLOID AND BETA-AMYLOID PRECURSOR PROTEIN EPITOPES DISTINGUISH ALZHEIMER FROM NON-ALZHEIMER SENILE PLAQUES
    ARAI, H
    LEE, VMY
    OTVOS, L
    GREENBERG, BD
    LOWERY, DE
    SHARMA, SK
    SCHMIDT, ML
    TROJANOWSKI, JQ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (06) : 2249 - 2253
  • [2] BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371
  • [3] BRION JP, IN PRESS BIOCH J
  • [4] BRION JP, 1990, DEMENTIA, V1, P304
  • [5] A4 AMYLOID PROTEIN DEPOSITION AND THE DIAGNOSIS OF ALZHEIMERS-DISEASE - PREVALENCE IN AGED BRAINS DETERMINED BY IMMUNOCYTOCHEMISTRY COMPARED WITH CONVENTIONAL NEUROPATHOLOGIC TECHNIQUES
    DAVIES, L
    WOLSKA, B
    HILBICH, C
    MULTHAUP, G
    MARTINS, R
    SIMMS, G
    BEYREUTHER, K
    MASTERS, CL
    [J]. NEUROLOGY, 1988, 38 (11) : 1688 - 1693
  • [6] DIFFUSE LEWY BODY DISEASE - LIGHT AND ELECTRON-MICROSCOPIC IMMUNOCYTOCHEMISTRY OF SENILE PLAQUES
    DICKSON, DW
    CRYSTAL, H
    MATTIACE, LA
    KRESS, Y
    SCHWAGERL, A
    KSIEZAKREDING, H
    DAVIES, P
    YEN, SHC
    [J]. ACTA NEUROPATHOLOGICA, 1989, 78 (06) : 572 - 584
  • [7] EFFECTS OF INJECTED ALZHEIMER BETA-AMYLOID CORES IN RAT-BRAIN
    FRAUTSCHY, SA
    BAIRD, A
    COLE, GM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (19) : 8362 - 8366
  • [8] SEGREGATION OF A MISSENSE MUTATION IN THE AMYLOID PRECURSOR PROTEIN GENE WITH FAMILIAL ALZHEIMERS-DISEASE
    GOATE, A
    CHARTIERHARLIN, MC
    MULLAN, M
    BROWN, J
    CRAWFORD, F
    FIDANI, L
    GIUFFRA, L
    HAYNES, A
    IRVING, N
    JAMES, L
    MANT, R
    NEWTON, P
    ROOKE, K
    ROQUES, P
    TALBOT, C
    PERICAKVANCE, M
    ROSES, A
    WILLIAMSON, R
    ROSSOR, M
    OWEN, M
    HARDY, J
    [J]. NATURE, 1991, 349 (6311) : 704 - 706
  • [9] TAU IN ALZHEIMERS-DISEASE AND DOWNS-SYNDROME IS INSOLUBLE AND ABNORMALLY PHOSPHORYLATED
    HANGER, DP
    BRION, JP
    GALLO, JM
    CAIRNS, NJ
    LUTHERT, PJ
    ANDERTON, BH
    [J]. BIOCHEMICAL JOURNAL, 1991, 275 : 99 - 104
  • [10] Hyman BT, 1989, HIPPOCAMPUS NEW VIST, P499